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ABSTRACT
The phage 029 protein p5, required in vivo in the elongation step of 429 DNA replication, was
highly purified from Escherichia coli cells harbouring a gene 5-containing plasmid and from 429-
infected Bacillus subtilis. The protein was characterized as the gene 5 product by amino acid analysis
and NH2-terminal sequence determination. The purified protein p5 was shown to bind to single-
stranded DNA and to protect it against nuclease degradation. No effect of protein p5 was observed
either on the formation of the p3-dAMP initiation complex or on the rate of elongation. However,
protein p5 greatly stimulated 429 DNA-protein p3 replication at incubation times where the replication
in the absence of p5 leveled off.
INTRODUCTION
The Bacillus subtilis phage 429 has a linear, double- stranded DNA 19,285 bp long (1)
with the terminal protein p3 covalently linked at the two 5' ends (2). In vivo replication
of 429 starts at either DNA end primed by the terminal protein and proceeds by a strand-
displacement mechanism (3-5). Replication of the parental strand being displaced probably
starts at the opposite end before complete strand-displacement has occurred, as indicated
by the fact that in vivo replicative intermediates consisting of double-stranded DNA with
two single-stranded tails of different length have been observed by electron microscopy (3).
A purified in vitro system able to replicate 429 DNA has been developed. This system,
which requires the terminal protein p3 and the 429 DNA polymerase p2, can initiate 429
DNA-protein p3 replication by the formation of the protein p3-dAMP initiation complex
catalyzed by the DNA polymerase (6,7), which is able to elongate the initiation complex
further to produce full-length 429 DNA (8). Other viral proteins known to be involved
in 029 DNA replication in vivo are the products of genes 1, 5, 6 and 17 (9-11). The
function of the gene 1 and 17 products is presently unknown. The viral protein p6 has
been purified and shown to interact specifically with the 429 DNA ends stimulating the
formation of the p3-dAMP complex and the transition from initiation to elongation when
added to the minimal in vitro system containing terminal protein and DNA polymerase
(12-14). By in vivo shift-up experiments using ts 5 mutants, the gene 5 product has been
shown to be required in an elongation step of 429 DNA replication (15). Gene 5 has been
recently characterized, cloned under the control of the PL promoter of phage lambda and
protein p5 has been overproduced in E. coli (16). In this paper we report the purification
of protein p5 and its function in binding to single-stranded DNA. The stimulation of 429
DNA-protein p3 replication by protein p5 is also shown.
(C IRL Press
Volume 17 Number 10 1989 Nucleic Acids Research
3663
Nucleic Acids Research
Lysate+AS DEAE-C+AS AS super AS pellet
Figure 1. SDS-polyacrylamide gel electrophoresis of purified protein p5. Proteins at various purification steps
were subjected to SDS-electrophoresis in slab gels containing a 10-20% acrylanilde gradient. After electrophoresis
the proteins were stained as indicated in Materials and Methods, section c. Lanes: a) extract precipitated with
ammonium sulfate to 65% saturation (80 ,ug); b) DEAE-cellulose, 50mM NaCl eluate precipitate with an-imonium
sulfate to 65% saturation (4.2 Atg); c) supematant from the 1.4 M ammonium sulfate precipitation (2.2 Atg); d)
1.4 M ammonium sulfate precipitate (4.1 /kg). The position of protein p5 is indicated.
MATERALUS AND METHODS
a) Bacterial strains, plasmids, phage, proteins and radioactive comtpounds
The E. coi X lysogen K-12Atrp (XN-cI857AH1) (K-12AHIAtrp) (17) was obtained from
M. Zabeau. The gene 5-containing recombinant plasmid pGM26 with gene 5 under the
control of the PL promoter of phage X was as described (16). The 4)29 delayed lysis
mutant susl4(1242) was as described (18).
Restriction endonucleases, the Klenow fragment of E. coli DNA polymerase I and
nuclease P1 were from Boehringer Mannheim. The 4)29 DNA polymerase p2 and the
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Table 1. Summary of protein p5 purification
Total protein, Protein p5, Total protein p5,
mg % mg
Extract 720 1.4 10.1
DEAE-cellulose 7.4 47 3.5
AS, 65% 4.2 68 2.9
AS, 1.4 M 2.5 99 2.5
Total protein was determined by the method of Bradford (24). SDS-polyacrylamide gel electrophoresis was
carried out at the different purification steps to follow the presence of protein p5. The % of protein p5 was
determined by densitometry of the stained bands.
terminal protein p3 were purified as described (6,19). [a-32P]dATP (-400 Ci/mmol) and['y_32P] ATP (3000 Ci/mmol) were from Amersham International plc.
b) Preparation and labelling of nucleic acids
Proteinase K-treated 429 DNA and 429 DNA-protein p3 complex were isolated as
described (20,21). The 429 DNA HindHI L fragment, 273 bp long, from the right 4)29
DNA end, was isolated by electrophoresis on 3.5% polyacrylamide gels in 0.1 M Tris-
borate, pH 8.3, 2 mM EDTA (TBE) and labelled by filling-in with the Klenow enzyme.
A 253 nucleotide long single-stranded DNA fragment from an internal region of 029 DNA,
from nucleotide 11315 to 11568 (1), labelled at the 5' end with polynucleotide kinase and
[Fy-32P]ATP, was a gift from I. Barthelemy. 3H-labelled M13-DNA was prepared by in
vivo labelling with 3H-thymidine and isolation from purified phage particles.
c) Purification ofprotein p5
Ten g of E. coli Kl2AH lAtrp cells harbouring the gene 5-containing recombinant plasmid
pGM26, induced for 2.5 h at 42°C, were ground with alumina (20 g) and extracted with
buffer A (50 mM Tris-HCl, pH 7.5, 5% glycerol) containing 0.3 M KCl. The lysate was
centrifuged for 10 min at 16,500 x g and the pellet re-extracted with the same buffer. The
two supernatants were pooled and precipitated with ammonium sulfate to 65% saturation.
The pellet was dissolved in buffer A, dialyzed against the same buffer, diluted with buffer
A + 20% glycerol and passed through a DEAE-cellulose column (2.7 cmx 1O cm)
equilibrated with buffer A + 10 mM NaCl. The column was washed first with buffer
A + 20% glycerol, then with buffer A, and protein p5 was finally eluted with buffer A
+ 50 mM NaCl. The fractions containing protein p5 were pooled and precipitated with
ammonium sulfate to 65% saturation. The pellet was resuspended in 1.2 ml of buffer A
+ 1.4 M ammonium sulfate and 50% glycerol. The pellet remaining after centrifugation,
containing most of protein p5, was dissolved in buffer A + 50% glycerol. Protein p5
was purified by a similar procedure from B. subtilis cells infected with the 429 delayed
lysis mutant susl4(1242). In all purification steps protein p5 was followed by SDS-
polyacrylamide gel electrophoresis.
When indicated, after the last purification step, protein p5 was centrifuged for 24 h at
260,000 xg at 0°C in a 5 ml 15 to 30% (v/v) glycerol gradient in 50 mM Tris-HCl, pH
7.5, 0.2 M NaCl. After centrifugation, 0.2 ml fractions were collected and the presence
of protein p5 was determined as indicated above.
Electrophoresis of proteins was carried out in slab gels containing 10-20% acrylamide
gradients in the presence of 0.1 % SDS (22). After electrophoresis the proteins were stained
as described by Fairbanks et al. (23). Protein concentration was determined by the method
of Bradford (24).
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Table 2. Amino acid composition of purified protein p5
Residue Predicteda Observedb
Asp + Asn 13 12.1
Thr 14 13.6
Ser 10 9.8
Glu + Gln 15 14.8
Pro 1 1.1
Gly 9 9.4
Ala 12 12.1
Val 9 9.0
Met 1 0.8
lie 9 8.6
Leu 9 9.2
Tyr 3 2.4
Phe 7 6.9
Trp 0 N.D.
Lys 10 10.0
His 1 1.1
Arg 1 0.9
aAmino acid composition predicted from the nucleotide sequence (29). The amino-terminal Met has been
included.
bAmino acid composition of purified protein p5. Each value represents the average after 24, 48 and 72 h
hydrolysis, except the values for Thr and Ser that were extrapolated to zero hours of hydrolysis. Values represent
residues per molecule. Trp was not determined (N.D.).
d) Amino acid analysis and protein sequence determination
Purified protein p5 was hydrolyzed with 100 Atl of 5.7 M HCl containing 0.05% (v/v)
2-mercaptoethanol in evacuated and sealed tubes at 110°C for 24, 48 and 72 h. The analysis
were performed on a Beckman 121-M analyzer equipped with a Beckman integrator 126
data system.
The NH2-end of purified protein p5 was sequenced in a Beckman sequencer (model
890 D) according to the method of Edman and Begg (25). The sequence of the protein
was determined using the Beckman protein/peptide/micro/macrosequencing program as
described (26).
e) Gel retardation assay
Protein p5 in the amount indicated in each case was incubated for 30 min at 4°C in a
final volume of 20 AI of a buffer containing 12 mM Tris-HCl, pH 7.5 and 1 mM EDTA
with 32P-labelled HindHI L fragment, 273 bp long, from the right end of 029 DNA or
with the 32P-labelled single-stranded internal DNA fragment, 253 nucleotides long, which
was described above. Protein p5-DNA complexes were resolved in low ionic strength
polyacrylamide gels essentially as described (27). After electrophoresis the gels were dried
and autoradiographed.
f) Assay for the formation of the p3-dAMP initiation complex
The incubation mixture for the initiation reaction contained, in 20 Al, 50 mM Tris-acetate,
pH 7.5, 10 mM Mg acetate, 1 mM dithiothreitol, 10 mM (NH4)2SO4, 20 mM NaCl, 25
jig of bovine serum albumin, 429 DNA-protein p3 (0.22 Atg), 0.25 or 40 AM [a-32p]
dATP (2 ACi) and purified proteins p2 (24 ng) and p3 (15 ng), in the absence or presence
of purified protein p5. When indicated, elongation was allowed to occur in the presence
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Figure 2. Binding of protein p5 to single-stranded DNA. A 32P-labelled single-stranded DNA fragment 253
nucleotides long (10 ng) was incubated with the indicated amounts of purified protein p5 (A) or with 1 /g of
protein p5 in the presence of the indicated amounts of non-radioactive, heat-denatured HindIll L fragment, 273
nucleotides long (B). The protein-DNA complexes were separated by polyacrylamide gel electrophoresis as indicated
in Materials and Methods, section e. After electrophoresis the gels were dried and autoradiographed.
of 40 ltM each dCTP, dGTP, dTTP and [a-32P]dATP (2 MCi) in the absence or presence
of protein p5. After the indicated times at 30°C the reaction was stopped and the samples
were treated with micrococcal nuclease and subjected to SDS-polyacrylamide gel
electrophoresis as described (13).
g) Replication assay
The incubation mixture contained, in 20 lil, 50 mM Tris-acetate, pH 7.5, 10 mM Mg
acetate, 1 mM dithiothreitol, 10 mM (NH4)2SO4, 029 DNA-protein p3 (0.22 itg), 40 ,t4M
each dCTP, dGTP, dTTP and [a_32P] dATP (2 ,tCi), bovine serum albumin (25 ,ug) and
purified proteins p2 (24 ng) and p3 (15 ng). When indicated, purified protein p5 was added.
After the indicated times at 30°C the reaction was stopped and the samples were filtered
through Sephadex G-50 spun columns in the presence of0.1% SDS. The Cerenkov radiation
of the excluded fraction was counted. When the rate of elongation was to be determined,
the labelled DNA from the excluded fraction was treated with proteinase K and subjected
to alkaline agarose gel electrophoresis (28).
3667
Nucleic Acids Research
100
80
02
0. 60
0
a
Cc 40
.j ~~~~~~0
-j
O 20.
z
I
1 2 3
PROTEIN p5, (9g)
Figure 3. Protection by protein p5 of single-stranded DNA against nuclease degradation. 3H-labelled M13-DNA
( *, 20 ng or o, 100 ng) was incubated in a final volume of 20 !d of a buffer containing 30 mM Tris-acetate,
pH 7.5, 10 mM Mg acetate and 0.1 rmM ZnC12 with the indicated amounts of purified protein p5 for 3 min
at 30°C. Then, nuclease P1 (0.4 tog) was added and, after 5 min at 30°C, the trichloroacetic acid-insoluble
radioactivity was determined.
RESULTS AND DISCUSSION
1. Purification ofprotein p5
E. coli K12AHlAtrp cells carrying the gene 5-containing recombinant plasmid pGM26
or B. subtilis cells infected with the phage 029 mutant susl4(1242) were used as a source
of protein p5 for purification. The protein p5 present in the E. coli extracts amounted
to - 1.4% of the total protein after 2.5 h of induction at 42°C and that present in the
B. subtilis extracts was - 2.7% of the total protein. The extracts, after precipitation with
ammonium sulfate, were purified by DEAE-cellulose chromatography; most of protein
p5 was eluted with 50 mM NaCl. After concentration with ammonium sulfate to 65%
saturation, protein p5 was selectively precipitated with 1.4 M ammonium sulfate. Figure
1 shows the analysis by SDS-polyacrylamide gel electrophoresis of the different fractions
of the purification from the E. coli cells. Densitometric analysis of the protein at the final
step indicated that p5 was about 99% pure. Table 1 shows a summary of the purification.
About 2.5 mg and 4 mg of purified protein p5 were obtained from 10 g of E. coli and
B. subtilis cells, respectively.
2. Amino acid analysis ofpurified protein p5
Table 2 shows that the amino acid analysis of protein p5 purified from E. coli cells gives
values very similar to those deduced from the DNA sequence of gene 5 (29). Moreover,
the NH2- terminal sequence of the purified protein p5 showed the sequence Met-Glu-Asn-
Thr-Asn-Ile-Val, in agreement with the one predicted from the nucleotide sequence.
3. Protein p5 binds to single-stranded DNA and protects it against nuclease degradation
When the binding of protein p5 to the double-stranded HindI L fragment, 273 bp long,
was studied by a gel retardation assay, only a very small amount of DNA was shifted
with up to 4 yg of protein (not shown). However, as shown in Fig. 2A, when a 253
nucleotide long single-stranded DNA fragment was used, some retardation of the band
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Figure 4. Effect of protein p5 on the formation of the p3-dAMP initiation complex. 429 DNA-protein p3 complex
was incubated with purified proteins p2 and p3 and either 0.25 or 40 AM [c(-32P]dATP (2 PCi) as indicated
in Materials and Methods, section f, in the absence or presence of purified protein p5 (9 lLg). After incubation
for the indicated times at 30°C the samples were processed and subjected to SDS-polyacrylamide gel electrophoresis
as described in Materials and Methods, section f.
was seen even at 0.25 ug of protein p5, the band shift being increased with amounts of
up to 4 ug of protein p5. The binding of 1 yg of protein p5 to the single-stranded DNA
fragment was resistant to 120 mM NaCl, some inhibition being observed at 160 mM NaCl
(not shown). On the other hand, as shown in Fig. 2B, most of the binding of 1 yg of
protein p5 to 10 ng of the single-stranded DNA fragment was competed for with 75 ng
of non-radioactive heat-denatured HindH L fragment. The mechanism of interaction of
protein p5 with single-stranded DNA is being studied further. In addition, Fig. 3 shows
that binding of protein p5 to single-stranded DNA protects the latter against nuclease P1
degradation. These results suggest that a possible role of protein p5 in the elongation stage
of c29 DNA replication in vivo could be the protection of the single-strand that is being
displaced against nuclease degradation (see later). Consistent with such a role in 429 DNA
replication is the fact that p5 is a very abundant protein in ¢29-infected B. subtilis cells
(-700,000 molecules per cell).
4. Stimulation of 429 DNA-protein p3 replication by protein p5
Fig. 4A shows that protein p5 up to 9 yg had no effect on the in vitro formation of the
protein p3-dAMP initiation complex (which can occur at low dATP concentration) or on
elongation of the complex to p3-(dAMP)2 and p3-(dAMP)3 which takes place at a higher
dATP concentration, as it was expected from the in vivo results which indicated a role
of protein p5 in the elongation of replication (15). When the effect of protein p5 on 429
DNA-protein p3 replication was tested, only a small stimulation was obtained at incubation
times of 10 min or shorter and no effect on the rate of elongation was observed (Fig.
SA, inset). At longer incubation times the stimulation by protein p5 greatly increased;
whereas the replication of the control without protein p5 leveled off, in its presence the
replication continued essentially in a linear way for over 40 min (Fig. SA). As a control,
when protein p5 was heated for S min at 90°C, no stimulation of replication was observed.
The net DNA mass synthesized after 40 min of incubation in the absence of protein p5
was 80 ng. In the presence of protein p5 the net DNA mass synthesized was 390 ng
indicating that approximately two rounds of replication occurred on average. Analysis by
alkaline agarose gel electrophoresis of the DNA synthesized in the presence of protein
p5 showed the presence of full-length 429 DNA as the major product after 7 min of
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and autoradiographed. B. As in A, except that 9g of protein p5 were added at zero time or after 30minc at
30°C when indicated. After incubation for the indicated times at 30°C the samples were processed and the
incorporated radioactivity counted as described in Materials and Methods, section g. At the times indicated in
the inset after 30im of incubation without protein p5 (time*) half of the samples in B were treated with micrcoccal
nuclease and subjected to SDS-polyacrylamide gel electrophoresis as described in Materials and Methods, section
f.
incubation (Fig. 5A, inset and not shown). lnaddition, as shown in Fig. 5B, the stimulation
by protein pS added at 30mDafter replication had started, when the DNA synthesis
essentially leveled off, was similar to that obtained when protein p5 was present from the
beginning. It can be also seen thatate replication proceeded in a linear way for at least
90m2 in the presence of protein p5 added either at zero time or after 30 mn of incubation.
When the amount of the p3-dAMP complex resulting from micrococcal nuclease degradation
of the elongation products was determined in the samples elongated in the absence of protein
p5 or in the presence of the protein, added after 30 min of incubation, stimulation by protein
p5 could be seen (Fig. SB, inset). These results suggest that protein p5 stimulates 4)29
DNA replication because it allows reinitiations to occur, possibly by overcoming inhibition
by the increasing amounts of single-stranded DNA produced during replication. The
stimulation by protein p5 was also seen in the presence of the viral protein p6 in an additive
way (results not shown), suggesting that the two proteins act independently during in vitro
4)29 DNA-protein p3 replication.
To analyze the effect of protein p5 on the production of single-stranded DNA, 4)29 DNA-
protein p3 was treated with the restriction nuclease Clal that produces two fragments, 6147
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Figure 6. Protection by protein p5 against nuclease P1 in the replication of Clal fragments of k/29 DNA-protein
p3. 0/29 DNA-protein p3 complex treated with ClaI was incubated with purified proteins p2 and p3 in the presence
of 40 jiM each dCTP, dGTP, dTTP and [ax-32P]dATP (1 /Ci) as indicated in Materials and Methods, section
g, in the absence or presence of purified protein p5 (9 jig), without (lanes a and e) or with (lanes b-d and f-h)
0.2 mM ZnC12 and nuclease P1 as indicated. After incubation for 40 min at 30°C the samples were subjected
to electrophoresis in 0.7% agarose gels in TBE. After electrophoresis the gels were dried and autoradiographed.
and 13138 bp long, with protein p3 present at only one end. Fig. 6 shows that the amount
of displaced single-strand was greatly increased in the presence of protein p5 (lanes a and
g) in agreement with the above results on the reinitiations that occur in the presence of
protein p5. In addition, the presence of protein p5 protected the single-stranded DNA against
degradation by nuclease P1 (Fig. 6, lanes b-d and f-h). These results suggest that a role
of protein p5 in vivo could be to protect the single- stranded DNA against nuclease
degradation. In addition, the finding that protein p5 prevents the cessation of 429 DNA-
protein p3 replication at long incubation times suggests that the protein, by binding to the
single-stranded DNA produced, may maintain it in extended form and, thus, avoid
inhibition. Analysis by electron microscopy of 429 DNA replication in the presence of
protein p5 supports this possibility (J.M. Sogo, G.M. and M.S., unpublished results).
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